(NYSE: TMO) Thermo Fisher Scientific's forecast annual revenue growth rate of 5.08% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.33%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.27%.
Thermo Fisher Scientific's revenue in 2026 is $46,336,000,000.On average, 31 Wall Street analysts forecast TMO's revenue for 2026 to be $17,870,625,826,952, with the lowest TMO revenue forecast at $17,266,458,761,628, and the highest TMO revenue forecast at $18,668,910,217,426. On average, 31 Wall Street analysts forecast TMO's revenue for 2027 to be $18,811,632,669,822, with the lowest TMO revenue forecast at $18,049,953,260,662, and the highest TMO revenue forecast at $20,107,596,907,252.
In 2028, TMO is forecast to generate $19,913,479,582,102 in revenue, with the lowest revenue forecast at $19,024,607,106,558 and the highest revenue forecast at $21,262,687,428,716.